Viewing Study NCT06548360


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-01 @ 10:50 PM
Study NCT ID: NCT06548360
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2024-08-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Sponsor: Incyte Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NonSegmental Vitiligo View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NonSegmental Vitiligo View
None pediatric View